25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

OSL (Oncosil) Stock Analysis
Buy, Hold or Sell?

Let's analyze Oncosil together

I guess you are interested in Oncosil Medical Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Oncosil’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Oncosil’s Price Targets

I'm going to help you getting a better view of Oncosil Medical Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Oncosil Medical Ltd

I send you an email if I find something interesting about Oncosil Medical Ltd.

1. Quick Overview

1.1. Quick analysis of Oncosil (30 sec.)










1.2. What can you expect buying and holding a share of Oncosil? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
A$0.16
Expected worth in 1 year
A$0.82
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
A$0.65
Return On Investment
51.9%

For what price can you sell your share?

Current Price per Share
A$1.26
Expected price per share
A$1.2 - A$1.66
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Oncosil (5 min.)




Live pricePrice per Share (EOD)
A$1.26
Intrinsic Value Per Share
A$-9.39 - A$-3.49
Total Value Per Share
A$-9.23 - A$-3.32

2.2. Growth of Oncosil (5 min.)




Is Oncosil growing?

Current yearPrevious yearGrowGrow %
How rich?$2m$3.1m-$1m-52.6%

How much money is Oncosil making?

Current yearPrevious yearGrowGrow %
Making money-$9.8m-$7.8m-$2m-21.1%
Net Profit Margin-1,289.7%-2,306.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Oncosil (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#252 / 292

Most Revenue
#246 / 292

Most Profit
#237 / 292

Most Efficient
#273 / 292
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Oncosil?

Welcome investor! Oncosil's management wants to use your money to grow the business. In return you get a share of Oncosil.

First you should know what it really means to hold a share of Oncosil. And how you can make/lose money.

Speculation

The Price per Share of Oncosil is A$1.255. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Oncosil.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Oncosil, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.16. Based on the TTM, the Book Value Change Per Share is A$0.16 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Oncosil.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.53-41.8%-0.53-41.8%0.00-0.3%-0.18-14.2%-0.11-8.7%-0.06-4.6%
Usd Book Value Change Per Share0.118.5%0.118.5%0.00-0.3%0.032.7%0.021.4%0.010.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.1%
Usd Total Gains Per Share0.118.5%0.118.5%0.00-0.3%0.032.7%0.021.4%0.010.9%
Usd Price Per Share0.79-0.79-0.00-0.27-0.17-0.13-
Price to Earnings Ratio-1.50--1.50--0.75--1.17--2.59--8.12-
Price-to-Total Gains Ratio7.38-7.38--0.65-0.50--29.65--12.49-
Price to Book Ratio7.28-7.28-1.87-3.54-3.86-4.65-
Price-to-Total Gains Ratio7.38-7.38--0.65-0.50--29.65--12.49-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.821774
Number of shares1216
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.110.02
Usd Total Gains Per Share0.110.02
Gains per Quarter (1216 shares)129.5521.98
Gains per Year (1216 shares)518.2287.94
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1051850808878
20103610260176166
30155515440264254
40207320620352342
50259125800440430
60310930980528518
70362836160616606
80414641340704694
90466446520791782
100518251700879870

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.021.00.00.0%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%4.06.00.040.0%8.013.00.038.1%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%1.00.09.010.0%1.00.020.04.8%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%4.06.00.040.0%8.013.00.038.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Oncosil Medical Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1630.1630%-0.006+104%0.051+216%0.028+489%0.015+989%
Book Value Per Share--0.1650.1650%0.002+7624%0.058+182%0.039+319%0.031+432%
Current Ratio--1.6691.6690%3.256-49%4.028-59%5.136-68%8.145-80%
Debt To Asset Ratio--0.5660.5660%0.295+92%0.333+70%0.264+114%0.179+216%
Debt To Equity Ratio--1.3031.3030%0.418+211%0.628+108%0.453+188%0.279+367%
Dividend Per Share----0%-0%-0%-0%0.002-100%
Enterprise Value--23657730.20023657730.2000%11396972.000+108%19069095.400+24%35165230.735-33%65117199.867-64%
Eps---0.802-0.8020%-0.005-99%-0.272-66%-0.167-79%-0.089-89%
Ev To Ebitda Ratio---1.571-1.5710%-0.882-44%-1.479-6%-2.977+90%-7.512+378%
Ev To Sales Ratio--20.20720.2070%22.060-8%34.172-41%127.932-84%77.137-74%
Free Cash Flow Per Share---0.641-0.6410%-0.005-99%-0.219-66%-0.135-79%-0.072-89%
Free Cash Flow To Equity Per Share--0.0340.0340%-0.002+106%0.010+237%0.004+695%0.007+415%
Gross Profit Margin--1.0191.0190%1.016+0%1.016+0%1.029-1%1.333-24%
Intrinsic Value_10Y_max---3.489----------
Intrinsic Value_10Y_min---9.395----------
Intrinsic Value_1Y_max---0.132----------
Intrinsic Value_1Y_min---0.405----------
Intrinsic Value_3Y_max---0.563----------
Intrinsic Value_3Y_min---1.689----------
Intrinsic Value_5Y_max---1.193----------
Intrinsic Value_5Y_min---3.480----------
Market Cap23628156.080+4%22592659.20022592659.2000%8877568.000+154%15274235.733+48%29056520.335-22%56333205.367-60%
Net Profit Margin---12.897-12.8970%-23.061+79%-22.269+73%-32.411+151%-17.112+33%
Operating Margin---12.896-12.8960%-25.083+94%-22.943+78%-34.509+168%-18.559+44%
Operating Ratio--14.22914.2290%26.228-46%20.419-30%28.267-50%15.581-9%
Pb Ratio7.613+4%7.2807.2800%1.874+288%3.536+106%3.857+89%4.649+57%
Pe Ratio-1.565-5%-1.496-1.4960%-0.745-50%-1.169-22%-2.586+73%-8.115+442%
Price Per Share1.255+4%1.2001.2000%0.004+29900%0.405+196%0.262+358%0.194+517%
Price To Free Cash Flow Ratio-1.956-5%-1.871-1.8710%-0.805-57%-1.313-30%-2.913+56%-8.430+351%
Price To Total Gains Ratio7.713+4%7.3757.3750%-0.653+109%0.505+1361%-29.653+502%-12.488+269%
Quick Ratio--1.5671.5670%2.954-47%3.801-59%4.936-68%8.270-81%
Return On Assets---2.112-2.1120%-1.773-16%-1.625-23%-1.286-39%-0.867-59%
Return On Equity---4.865-4.8650%-2.515-48%-2.843-42%-2.076-57%-1.286-74%
Total Gains Per Share--0.1630.1630%-0.006+104%0.051+216%0.028+489%0.017+858%
Usd Book Value--2032185.5512032185.5510%3101400.613-34%3867777.660-47%5314315.679-62%7612462.459-73%
Usd Book Value Change Per Share--0.1070.1070%-0.004+104%0.034+216%0.018+489%0.010+989%
Usd Book Value Per Share--0.1080.1080%0.001+7624%0.038+182%0.026+319%0.020+432%
Usd Dividend Per Share----0%-0%-0%-0%0.001-100%
Usd Enterprise Value--15491081.73515491081.7350%7462737.266+108%12486443.668+24%23026193.085-33%42638742.473-64%
Usd Eps---0.525-0.5250%-0.004-99%-0.178-66%-0.110-79%-0.058-89%
Usd Free Cash Flow---7908193.122-7908193.1220%-7216810.756-9%-7524113.634-5%-7000797.605-11%-5542988.667-30%
Usd Free Cash Flow Per Share---0.420-0.4200%-0.003-99%-0.143-66%-0.088-79%-0.047-89%
Usd Free Cash Flow To Equity Per Share--0.0230.0230%-0.001+106%0.007+237%0.003+695%0.004+415%
Usd Market Cap15471716.601+4%14793673.24414793673.2440%5813031.526+154%10001569.558+48%19026209.515-22%36886982.875-60%
Usd Price Per Share0.822+4%0.7860.7860%0.003+29900%0.265+196%0.171+358%0.127+517%
Usd Profit---9887377.851-9887377.8510%-7801287.200-21%-8372020.484-15%-7794456.850-21%-6068152.345-39%
Usd Revenue--766635.256766635.2560%338290.634+127%448560.263+71%327394.893+134%1354713.166-43%
Usd Total Gains Per Share--0.1070.1070%-0.004+104%0.034+216%0.018+489%0.011+858%
 EOD+6 -2MRQTTM+0 -0YOY+21 -173Y+21 -175Y+15 -2310Y+14 -26

3.3 Fundamental Score

Let's check the fundamental score of Oncosil Medical Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.565
Price to Book Ratio (EOD)Between0-17.613
Net Profit Margin (MRQ)Greater than0-12.897
Operating Margin (MRQ)Greater than0-12.896
Quick Ratio (MRQ)Greater than11.567
Current Ratio (MRQ)Greater than11.669
Debt to Asset Ratio (MRQ)Less than10.566
Debt to Equity Ratio (MRQ)Less than11.303
Return on Equity (MRQ)Greater than0.15-4.865
Return on Assets (MRQ)Greater than0.05-2.112
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Oncosil Medical Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.009
Ma 20Greater thanMa 501.595
Ma 50Greater thanMa 1001.534
Ma 100Greater thanMa 2001.331
OpenGreater thanClose1.350
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Oncosil Medical Ltd

OncoSil Medical Limited, a medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The company's lead product is OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.

Fundamental data was last updated by Penke on 2025-10-29 19:20:08.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Oncosil earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Oncosil to theΒ Medical Devices industry mean.
  • A Net Profit Margin of -1,289.7%Β means thatΒ $-12.90 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Oncosil Medical Ltd:

  • The MRQ is -1,289.7%. The company is making a huge loss. -2
  • The TTM is -1,289.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,289.7%TTM-1,289.7%0.0%
TTM-1,289.7%YOY-2,306.1%+1,016.4%
TTM-1,289.7%5Y-3,241.1%+1,951.4%
5Y-3,241.1%10Y-1,711.2%-1,529.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,289.7%-4.5%-1,285.2%
TTM-1,289.7%-5.8%-1,283.9%
YOY-2,306.1%-11.0%-2,295.1%
3Y-2,226.9%-12.3%-2,214.6%
5Y-3,241.1%-11.1%-3,230.0%
10Y-1,711.2%-9.6%-1,701.6%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Oncosil is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Oncosil to theΒ Medical Devices industry mean.
  • -211.2% Return on Assets means thatΒ Oncosil generatedΒ $-2.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Oncosil Medical Ltd:

  • The MRQ is -211.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -211.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-211.2%TTM-211.2%0.0%
TTM-211.2%YOY-177.3%-33.9%
TTM-211.2%5Y-128.6%-82.6%
5Y-128.6%10Y-86.7%-42.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-211.2%-1.4%-209.8%
TTM-211.2%-1.3%-209.9%
YOY-177.3%-2.4%-174.9%
3Y-162.5%-2.4%-160.1%
5Y-128.6%-2.2%-126.4%
10Y-86.7%-1.5%-85.2%
4.3.1.3. Return on Equity

Shows how efficient Oncosil is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Oncosil to theΒ Medical Devices industry mean.
  • -486.5% Return on Equity means Oncosil generated $-4.87Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Oncosil Medical Ltd:

  • The MRQ is -486.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -486.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-486.5%TTM-486.5%0.0%
TTM-486.5%YOY-251.5%-235.0%
TTM-486.5%5Y-207.6%-278.9%
5Y-207.6%10Y-128.6%-79.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-486.5%-1.1%-485.4%
TTM-486.5%-1.3%-485.2%
YOY-251.5%-2.4%-249.1%
3Y-284.3%-3.2%-281.1%
5Y-207.6%-3.9%-203.7%
10Y-128.6%-3.9%-124.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Oncosil Medical Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Oncosil is operatingΒ .

  • Measures how much profit Oncosil makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Oncosil to theΒ Medical Devices industry mean.
  • An Operating Margin of -1,289.6%Β means the company generated $-12.90 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Oncosil Medical Ltd:

  • The MRQ is -1,289.6%. The company is operating very inefficient. -2
  • The TTM is -1,289.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,289.6%TTM-1,289.6%0.0%
TTM-1,289.6%YOY-2,508.3%+1,218.6%
TTM-1,289.6%5Y-3,450.9%+2,161.3%
5Y-3,450.9%10Y-1,855.9%-1,595.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,289.6%-10.0%-1,279.6%
TTM-1,289.6%-12.8%-1,276.8%
YOY-2,508.3%-13.3%-2,495.0%
3Y-2,294.3%-9.4%-2,284.9%
5Y-3,450.9%-9.0%-3,441.9%
10Y-1,855.9%-8.6%-1,847.3%
4.3.2.2. Operating Ratio

Measures how efficient Oncosil is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Medical Devices industry mean).
  • An Operation Ratio of 14.23 means that the operating costs are $14.23 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Oncosil Medical Ltd:

  • The MRQ is 14.229. The company is inefficient in keeping operating costs low. -1
  • The TTM is 14.229. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ14.229TTM14.2290.000
TTM14.229YOY26.228-11.998
TTM14.2295Y28.267-14.038
5Y28.26710Y15.581+12.686
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ14.2291.293+12.936
TTM14.2291.304+12.925
YOY26.2281.215+25.013
3Y20.4191.282+19.137
5Y28.2671.283+26.984
10Y15.5811.263+14.318
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Oncosil Medical Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Oncosil is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Medical Devices industry mean).
  • A Current Ratio of 1.67Β means the company has $1.67 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Oncosil Medical Ltd:

  • The MRQ is 1.669. The company is able to pay all its short-term debts. +1
  • The TTM is 1.669. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.669TTM1.6690.000
TTM1.669YOY3.256-1.587
TTM1.6695Y5.136-3.467
5Y5.13610Y8.145-3.009
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6692.395-0.726
TTM1.6692.593-0.924
YOY3.2562.691+0.565
3Y4.0282.836+1.192
5Y5.1363.574+1.562
10Y8.1453.433+4.712
4.4.3.2. Quick Ratio

Measures if Oncosil is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Oncosil to theΒ Medical Devices industry mean.
  • A Quick Ratio of 1.57Β means the company can pay off $1.57 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Oncosil Medical Ltd:

  • The MRQ is 1.567. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.567. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.567TTM1.5670.000
TTM1.567YOY2.954-1.387
TTM1.5675Y4.936-3.369
5Y4.93610Y8.270-3.334
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5671.324+0.243
TTM1.5671.458+0.109
YOY2.9541.724+1.230
3Y3.8011.896+1.905
5Y4.9362.290+2.646
10Y8.2702.521+5.749
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Oncosil Medical Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of OncosilΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Oncosil to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.57Β means that Oncosil assets areΒ financed with 56.6% credit (debt) and the remaining percentage (100% - 56.6%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Oncosil Medical Ltd:

  • The MRQ is 0.566. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.566. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.566TTM0.5660.000
TTM0.566YOY0.295+0.271
TTM0.5665Y0.264+0.302
5Y0.26410Y0.179+0.085
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5660.414+0.152
TTM0.5660.426+0.140
YOY0.2950.393-0.098
3Y0.3330.397-0.064
5Y0.2640.407-0.143
10Y0.1790.455-0.276
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Oncosil is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Oncosil to theΒ Medical Devices industry mean.
  • A Debt to Equity ratio of 130.3% means that company has $1.30 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Oncosil Medical Ltd:

  • The MRQ is 1.303. The company is able to pay all its debts with equity. +1
  • The TTM is 1.303. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.303TTM1.3030.000
TTM1.303YOY0.418+0.885
TTM1.3035Y0.453+0.851
5Y0.45310Y0.279+0.174
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3030.642+0.661
TTM1.3030.667+0.636
YOY0.4180.584-0.166
3Y0.6280.646-0.018
5Y0.4530.632-0.179
10Y0.2790.753-0.474
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Oncosil generates.

  • Above 15 is considered overpriced butΒ always compareΒ Oncosil to theΒ Medical Devices industry mean.
  • A PE ratio of -1.50 means the investor is paying $-1.50Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Oncosil Medical Ltd:

  • The EOD is -1.565. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.496. Based on the earnings, the company is expensive. -2
  • The TTM is -1.496. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.565MRQ-1.496-0.069
MRQ-1.496TTM-1.4960.000
TTM-1.496YOY-0.745-0.751
TTM-1.4965Y-2.586+1.090
5Y-2.58610Y-8.115+5.530
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.565-0.733-0.832
MRQ-1.496-0.973-0.523
TTM-1.496-1.062-0.434
YOY-0.745-2.405+1.660
3Y-1.169-1.052-0.117
5Y-2.586-1.079-1.507
10Y-8.115-1.014-7.101
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Oncosil Medical Ltd:

  • The EOD is -1.956. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.871. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.871. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.956MRQ-1.871-0.086
MRQ-1.871TTM-1.8710.000
TTM-1.871YOY-0.805-1.065
TTM-1.8715Y-2.913+1.042
5Y-2.91310Y-8.430+5.517
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.956-1.422-0.534
MRQ-1.871-1.745-0.126
TTM-1.871-1.503-0.368
YOY-0.805-3.237+2.432
3Y-1.313-2.198+0.885
5Y-2.913-3.739+0.826
10Y-8.430-3.976-4.454
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Oncosil is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Medical Devices industry mean).
  • A PB ratio of 7.28 means the investor is paying $7.28Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Oncosil Medical Ltd:

  • The EOD is 7.613. Based on the equity, the company is overpriced. -1
  • The MRQ is 7.280. Based on the equity, the company is overpriced. -1
  • The TTM is 7.280. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD7.613MRQ7.280+0.334
MRQ7.280TTM7.2800.000
TTM7.280YOY1.874+5.405
TTM7.2805Y3.857+3.423
5Y3.85710Y4.649-0.793
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD7.6132.291+5.322
MRQ7.2802.126+5.154
TTM7.2802.317+4.963
YOY1.8742.492-0.618
3Y3.5362.751+0.785
5Y3.8573.894-0.037
10Y4.6494.298+0.351
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Oncosil Medical Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets7,148
Total Liabilities4,045
Total Stockholder Equity3,104
 As reported
Total Liabilities 4,045
Total Stockholder Equity+ 3,104
Total Assets = 7,148

Assets

Total Assets7,148
Total Current Assets6,724
Long-term Assets424
Total Current Assets
Cash And Cash Equivalents 5,110
Net Receivables 1,205
Other Current Assets 410
Total Current Assets  (as reported)6,724
Total Current Assets  (calculated)6,724
+/-0
Long-term Assets
Property Plant Equipment 424
Long-term Assets  (as reported)424
Long-term Assets  (calculated)424
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities4,028
Long-term Liabilities16
Total Stockholder Equity3,104
Total Current Liabilities
Short-term Debt 107
Accounts payable 1,915
Other Current Liabilities 2,006
Total Current Liabilities  (as reported)4,028
Total Current Liabilities  (calculated)4,028
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)16
Long-term Liabilities  (calculated)0
+/- 16
Total Stockholder Equity
Common Stock96,425
Retained Earnings -107,458
Accumulated Other Comprehensive Income 14,136
Total Stockholder Equity (as reported)3,104
Total Stockholder Equity (calculated)3,104
+/-0
Other
Capital Stock96,425
Cash and Short Term Investments 5,110
Common Stock Shares Outstanding 10,928
Liabilities and Stockholders Equity 7,148
Net Debt -5,040
Net Invested Capital 3,104
Net Working Capital 2,695
Property Plant and Equipment Gross 587
Short Long Term Debt Total 70



5.2. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-30
> Total Assets 
947
8,185
7,002
6,167
5,228
2,959
3,030
2,524
6,244
9,636
7,407
15,897
11,805
19,882
11,668
24,060
14,150
13,069
11,474
6,718
7,148
7,1486,71811,47413,06914,15024,06011,66819,88211,80515,8977,4079,6366,2442,5243,0302,9595,2286,1677,0028,185947
   > Total Current Assets 
918
3,447
2,538
2,296
1,988
1,919
3,030
2,521
3,592
9,617
7,352
15,805
11,689
19,796
11,606
23,921
13,620
12,745
11,235
6,329
6,724
6,7246,32911,23512,74513,62023,92111,60619,79611,68915,8057,3529,6173,5922,5213,0301,9191,9882,2962,5383,447918
       Cash And Cash Equivalents 
887
2,821
1,901
1,746
1,395
1,552
2,727
2,412
3,511
2,739
2,523
9,780
8,001
15,205
7,689
20,998
12,240
11,280
9,394
4,501
5,110
5,1104,5019,39411,28012,24020,9987,68915,2058,0019,7802,5232,7393,5112,4122,7271,5521,3951,7461,9012,821887
       Short-term Investments 
0
0
0
0
0
0
141
80
57
4,350
3,598
3,259
0
0
69
69
91
89
117
0
0
0011789916969003,2593,5984,3505780141000000
       Net Receivables 
0
611
608
534
499
332
134
5
14
137
75
2,297
3,446
4,441
3,781
2,806
1,181
908
1,286
1,240
1,205
1,2051,2401,2869081,1812,8063,7814,4413,4462,297751371451343324995346086110
       Other Current Assets 
31
14
29
15
95
35
27
25
10
2,391
1,157
469
243
150
136
118
198
557
555
466
410
4104665555571981181361502434691,1572,391102527359515291431
   > Long-term Assets 
28
4,738
4,464
3,871
3,240
1,040
0
2
2,651
17
55
92
115
86
62
138
531
325
239
390
424
42439023932553113862861159255172,651201,0403,2403,8714,4644,73828
       Property Plant Equipment 
3
1,078
804
520
254
140
0
2
4
17
55
92
115
86
62
138
531
325
239
390
424
42439023932553113862861159255174201402545208041,0783
       Goodwill 
0
1,841
1,841
1,841
1,841
900
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000009001,8411,8411,8411,8410
       Intangible Assets 
0
1,818
1,818
1,510
2,985
900
0
0
2,648
2,648
0
0
0
0
0
0
0
0
0
0
0
000000000002,6482,648009002,9851,5101,8181,8180
       Other Assets 
0
0
0
0
0
0
0
0
0
3
0
0
0
0
0
0
0
0
0
0
0
000000000003000000000
> Total Liabilities 
47
2,727
2,322
2,080
946
381
117
41
193
121
446
1,086
1,670
1,728
993
2,159
2,454
1,907
1,594
1,982
4,045
4,0451,9821,5941,9072,4542,1599931,7281,6701,086446121193411173819462,0802,3222,72747
   > Total Current Liabilities 
47
1,367
1,391
1,495
471
347
117
41
193
121
446
1,086
1,670
1,728
993
2,159
2,133
1,768
1,569
1,944
4,028
4,0281,9441,5691,7682,1332,1599931,7281,6701,086446121193411173474711,4951,3911,36747
       Short-term Debt 
0
214
180
149
296
0
141
80
57
4,350
3,598
3,259
0
0
110
110
163
165
292
64
107
10764292165163110110003,2593,5984,350578014102961491802140
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27
0
0
0
0
0
0000027000000000000000
       Accounts payable 
41
512
645
744
471
83
105
7
54
36
171
217
901
857
364
1,356
1,227
931
960
1,123
1,915
1,9151,1239609311,2271,356364857901217171365471058347174464551241
       Other Current Liabilities 
6
590
531
575
218
187
12
34
139
84
275
870
769
871
629
693
743
671
317
756
2,006
2,0067563176717436936298717698702758413934121872185755315906
   > Long-term Liabilities 
0
1,361
931
585
475
34
0
0
0
0
0
0
0
0
364
321
321
139
25
38
16
16382513932132136400000000344755859311,3610
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
321
139
25
38
0
038251393210000000000000000
       Other Liabilities 
0
412
188
0
0
0
0
0
0
3
0
0
0
0
0
0
0
0
0
0
0
0000000000030000001884120
> Total Stockholder Equity
900
5,457
4,680
4,087
4,282
2,578
2,913
2,483
6,051
9,512
6,961
14,811
10,135
18,155
10,675
21,901
11,696
11,163
9,880
4,736
3,104
3,1044,7369,88011,16311,69621,90110,67518,15510,13514,8116,9619,5126,0512,4832,9132,5784,2824,0874,6805,457900
   Common Stock
926
5,567
6,366
8,508
8,508
8,695
9,708
9,709
13,889
23,786
23,806
35,695
36,645
52,257
52,257
70,137
70,397
79,910
86,507
90,094
96,425
96,42590,09486,50779,91070,39770,13752,25752,25736,64535,69523,80623,78613,8899,7099,7088,6958,5088,5086,3665,567926
   Retained Earnings -107,458-92,781-84,368-73,025-62,298-51,864-47,602-39,036-30,496-23,480-18,712-15,831-8,960-8,081-7,650-6,192-4,480-4,596-1,829-155-26
   Accumulated Other Comprehensive Income 
0
45
143
175
254
75
855
855
1,122
1,558
1,867
2,596
3,986
4,933
6,020
3,628
3,597
4,278
7,741
7,424
14,136
14,1367,4247,7414,2783,5973,6286,0204,9333,9862,5961,8671,5581,12285585575254175143450
   Capital Surplus 000000000000000000000
   Treasury Stock000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
1,558
0
2,596
3,986
4,933
6,020
-18,273
-8,099
-6,885
0
1
0
010-6,885-8,099-18,2736,0204,9333,9862,59601,558000000000



5.3. Balance Sheets

Currency in AUD. All numbers in thousands.




5.4. Cash Flows

Currency in AUD. All numbers in thousands.




5.5. Income Statements

Currency in AUD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2025-06-30. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,171
Cost of Revenue-2,254
Gross Profit-1,083-1,083
 
Operating Income (+$)
Gross Profit-1,083
Operating Expense-14,406
Operating Income-15,489-15,489
 
Operating Expense (+$)
Research Development4,211
Selling General Administrative7,537
Selling And Marketing Expenses292
Operating Expense14,40612,039
 
Net Interest Income (+$)
Interest Income91
Interest Expense-1
Other Finance Cost-0
Net Interest Income90
 
Pretax Income (+$)
Operating Income-15,489
Net Interest Income90
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-15,100-15,878
EBIT - interestExpense = -15,100
-15,100
-15,099
Interest Expense1
Earnings Before Interest and Taxes (EBIT)-15,099-15,099
Earnings Before Interest and Taxes (EBITDA)-15,063
 
After tax Income (+$)
Income Before Tax-15,100
Tax Provision-0
Net Income From Continuing Ops-15,100-15,100
Net Income-15,100
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses16,660
Total Other Income/Expenses Net389-90
 

Technical Analysis of Oncosil
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Oncosil. The general trend of Oncosil is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Oncosil's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Oncosil Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Oncosil Medical Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.64 < 1.64 < 1.66.

The bearish price targets are: 1.28 > 1.28 > 1.2.

Know someone who trades $OSL? Share this with them.πŸ‘‡

Oncosil Medical Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Oncosil Medical Ltd. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Oncosil Medical Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Oncosil Medical Ltd. The current macd is -0.05641859.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Oncosil price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Oncosil. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Oncosil price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Oncosil Medical Ltd Daily Moving Average Convergence/Divergence (MACD) ChartOncosil Medical Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Oncosil Medical Ltd. The current adx is 29.30.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Oncosil shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Oncosil Medical Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Oncosil Medical Ltd. The current sar is 1.66495106.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Oncosil Medical Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Oncosil Medical Ltd. The current rsi is 29.01. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Oncosil Medical Ltd Daily Relative Strength Index (RSI) ChartOncosil Medical Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Oncosil Medical Ltd. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Oncosil price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Oncosil Medical Ltd Daily Stochastic Oscillator ChartOncosil Medical Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Oncosil Medical Ltd. The current cci is -201.77073625.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Oncosil Medical Ltd Daily Commodity Channel Index (CCI) ChartOncosil Medical Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Oncosil Medical Ltd. The current cmo is -60.49365982.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Oncosil Medical Ltd Daily Chande Momentum Oscillator (CMO) ChartOncosil Medical Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Oncosil Medical Ltd. The current willr is -98.2300885.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Oncosil Medical Ltd Daily Williams %R ChartOncosil Medical Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Oncosil Medical Ltd.

Oncosil Medical Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Oncosil Medical Ltd. The current atr is 0.07933191.

Oncosil Medical Ltd Daily Average True Range (ATR) ChartOncosil Medical Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Oncosil Medical Ltd. The current obv is 513,919.

Oncosil Medical Ltd Daily On-Balance Volume (OBV) ChartOncosil Medical Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Oncosil Medical Ltd. The current mfi is 18.51.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Oncosil Medical Ltd Daily Money Flow Index (MFI) ChartOncosil Medical Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Oncosil Medical Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-06-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-19MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-23MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-07-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-07-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-15MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-08-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-08-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-08-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-09-01STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-09-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-10MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-15ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-09-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-09-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-10-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-10-03STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-10-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-10-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-10-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-10-23STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-10-24STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-10-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-10-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Oncosil Medical Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Oncosil Medical Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.009
Ma 20Greater thanMa 501.595
Ma 50Greater thanMa 1001.534
Ma 100Greater thanMa 2001.331
OpenGreater thanClose1.350
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Oncosil with someone you think should read this too:
  • Are you bullish or bearish on Oncosil? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Oncosil? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Oncosil Medical Ltd

I send you an email if I find something interesting about Oncosil Medical Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Oncosil Medical Ltd.

Receive notifications about Oncosil Medical Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.